4.25% TRAVASOL AMINO ACID INJECTION WITHOUT ELECTRLYTES IN 10% DEXTROSE SOLUTION

Country: Canada

Language: English

Source: Health Canada

Active ingredient:

L-ALANINE; L-ARGININE; L-PROLINE; SERINE; GLYCINE; L-TYROSINE; DEXTROSE; L-LEUCINE; L-PHENYLALANINE; LYSINE (L-LYSINE HYDROCHLORIDE); METHIONINE; L-ISOLEUCINE; L-VALINE; HISTIDINE; L-THREONINE; TRYPTOPHAN

Available from:

BAXTER CORPORATION CLINTEC NUTRITION DIVISION

ATC code:

B05BA10

INN (International Name):

COMBINATIONS

Dosage:

880MG; 489MG; 289MG; 212.5MG; 438MG; 17MG; 10G; 310MG; 238MG; 246.5MG; 170MG; 255MG; 246.5MG; 204MG; 178.5MG; 76.5MG

Pharmaceutical form:

SOLUTION

Composition:

L-ALANINE 880MG; L-ARGININE 489MG; L-PROLINE 289MG; SERINE 212.5MG; GLYCINE 438MG; L-TYROSINE 17MG; DEXTROSE 10G; L-LEUCINE 310MG; L-PHENYLALANINE 238MG; LYSINE (L-LYSINE HYDROCHLORIDE) 246.5MG; METHIONINE 170MG; L-ISOLEUCINE 255MG; L-VALINE 246.5MG; HISTIDINE 204MG; L-THREONINE 178.5MG; TRYPTOPHAN 76.5MG

Administration route:

INTRAVENOUS

Units in package:

2000 ML

Prescription type:

Ethical

Therapeutic area:

CALORIC AGENTS

Product summary:

Active ingredient group (AIG) number: 1650849014; AHFS:

Authorization status:

CANCELLED POST MARKET

Authorization date:

2015-08-05